menu Search
Vabysmo

Vabysmo Description

faricimab

Manufacturer:

F. Hoffmann-La Roche

Distributor:

Roche
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Description
Active ingredient(s): Faricimab (genetically produced in CHO [Chinese Hamster Ovary] cells).
Faricimab (Vabysmo) for injection is a clear to opalescent, colorless to brownish-yellow solution in a single-dose glass vial, containing 28.8 mg faricimab in 0.24 mL solution. This provides a usable amount to deliver a single dose of 0.05 mL solution containing 6 mg of faricimab.
One single-dose (0.05 mL solution for injection) contains 0.028 mg sodium.
Sterile/Radioactive Statement: Sterile product.
Excipients/Inactive Ingredients: L-histidine, Acetic Acid, L-methionine, Polysorbate 20 (manufactured from genetically modified maize), Sodium Chloride, D-Sucrose (manufactured from genetically modified sugar beet), Water for Injection.